Overview

VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of telaprevir on the results of electrocardiograms in healthy volunteers. An electrocardiogram is an electric recording of the heart. Telaprevir is being investigated for the treatment of chronic hepatitis C virus infection.

Phase:

Phase 1

Details

Lead Sponsor:

Tibotec BVBA

Collaborator:

Vertex Pharmaceuticals Incorporated

Treatments:

Moxifloxacin
Norgestimate, ethinyl estradiol drug combination